Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
9.09M
-
Shares change
-
+8.66M
-
Total reported value, excl. options
-
$134M
-
Value change
-
+$128M
-
Number of buys
-
30
-
Price
-
$15.00
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q3 2018
32 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q3 2018.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.09M shares
of 84.7M outstanding shares and own 10.72% of the company stock.
Largest 10 shareholders include SV Health Investors, LLC (1.82M shares), CITADEL ADVISORS LLC (1.75M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.24M shares), Camber Capital Management LP (600K shares), COWEN INC. (417K shares), FMR LLC (400K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (358K shares), BlackRock Inc. (340K shares), SPHERA FUNDS MANAGEMENT LTD. (275K shares), and Tekla Capital Management LLC (250K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.